Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Ischemic Heart Disease

Free Subscription Articles published in Atherosclerosis Retrieve available abstracts of 128 articles: HTML format Text format

Single Articles

April 2019
1. DE BACKER G, Jankowski P, Kotseva K, Mirrakhimov E, et al
   Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.
   Atherosclerosis. 2019;285:135-146.
   PubMed     Text format     Abstract available
   
   
   March 2019
2. RUGE T, Carlsson AC, Kjoller E, Hilden J, et al
   Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease: A CLARICOR trial sub-study.
   Atherosclerosis. 2019;284:202-208.
   PubMed     Text format     Abstract available
   
   
   December 2018
3. SOARES AAS, Carvalho LSF, Bonilha I, Virginio VW, et al
   Adverse interaction between HDL and the mass of myocardial infarction.
   Atherosclerosis. 2018;281:9-16.
   PubMed     Text format     Abstract available
   
   
   November 2018
4. KIM YH, Her AY, Jeong MH, Kim BK, et al
   Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI.
   Atherosclerosis. 2018;280:166-173.
   PubMed     Text format     Abstract available
   
   
   
5. VAHAMURTO L, Pahkala K, Magnussen CG, Hutri-Kahonen N, et al
   Coronary heart disease risk factor levels in eastern and western Finland from 1980 to 2011 in the cardiovascular risk in Young Finns study.
   Atherosclerosis. 2018;280:92-98.
   PubMed     Text format     Abstract available
   
   
   
6. HUMPHRIES SE, Cooper JA, Capps N, Durrington PN, et al
   Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register.
   Atherosclerosis. 2018 Nov 12. pii: S0021-9150(18)31469.
   PubMed     Text format     Abstract available
   
   
   October 2018
7. YANG R, Song Z, Wu S, Wei Z, et al
   Toll-like receptor 4 contributes to a myofibroblast phenotype in cardiac fibroblasts and is associated with autophagy after myocardial infarction in a mouse model.
   Atherosclerosis. 2018;279:23-31.
   PubMed     Text format     Abstract available
   
   
   
8. KANURI SH, Ipe J, Kassab K, Gao H, et al
   Next generation MicroRNA sequencing to identify coronary artery disease patients at risk of recurrent myocardial infarction.
   Atherosclerosis. 2018;278:232-239.
   PubMed     Text format     Abstract available
   
   
   September 2018
9. WUOPIO J, Hilden J, Bring C, Kastrup J, et al
   Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study.
   Atherosclerosis. 2018;278:97-102.
   PubMed     Text format     Abstract available
   
   
   
10. SOLBU MD, Kolset SO, Jenssen TG, Wilsgaard T, et al
    Gender differences in the association of syndecan-4 with myocardial infarction: The population-based Tromso Study.
    Atherosclerosis. 2018;278:166-173.
    PubMed     Text format     Abstract available
    
    
    
11. ALKHALIL M, Biasiolli L, Akbar N, Galassi F, et al
    T2 mapping MRI technique quantifies carotid plaque lipid, and its depletion after statin initiation, following acute myocardial infarction.
    Atherosclerosis. 2018 Sep 6. pii: S0021-9150(18)31343.
    PubMed     Text format     Abstract available
    
    
    
12. BEYAN C, Beyan E
    Mean platelet volume may not have a role in the prediction of adverse events after percutaneous coronary intervention in patients with ST elevation myocardial infarction.
    Atherosclerosis. 2018;276:204-205.
    PubMed     Text format    
    
    
    
13. WANG Y, Zhu J, Handberg A, Overvad K, et al
    Association between plasma CD36 levels and incident risk of coronary heart disease among Danish men and women.
    Atherosclerosis. 2018;277:163-168.
    PubMed     Text format     Abstract available
    
    
    August 2018
14. BYUN JK, Choi BG, Rha SW, Choi SY, et al
    Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and non-ST-segment elevation myocardial infarction who underwent successful percutaneous coronary intervention.
    Atherosclerosis. 2018;277:130-135.
    PubMed     Text format     Abstract available
    
    
    July 2018
15. MACHADO GP, de Araujo GN, Wainstein M
    Reply to "Mean platelet volume may not have a role in the prediction of adverse events after percutaneous coronary intervention in patients with ST-elevation myocardial infarction".
    Atherosclerosis. 2018 Jul 21. pii: S0021-9150(18)31217.
    PubMed     Text format    
    
    
    May 2018
16. BALCER B, Dykun I, Schlosser T, Forsting M, et al
    Pericoronary fat volume but not attenuation differentiates culprit lesions in patients with myocardial infarction.
    Atherosclerosis. 2018 May 25. pii: S0021-9150(18)30278.
    PubMed     Text format     Abstract available
    
    
    
17. VENEGAS-PINO DE, Lagrotteria A, Wang PW, Morphet J, et al
    Evidence of extensive atherosclerosis, coronary artery disease and myocardial infarction in the ApoE(-/-):Ins2(+/Akita) mouse fed a western diet.
    Atherosclerosis. 2018;275:88-96.
    PubMed     Text format     Abstract available
    
    
    
18. MACHADO GP, Araujo GN, Carpes CK, Lech M, et al
    Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
    Atherosclerosis. 2018;274:212-217.
    PubMed     Text format     Abstract available
    
    
    
19. DONG SY, Yan ST, Wang ML, Li ZB, et al
    Associations of body weight and weight change with cardiovascular events and mortality in patients with coronary heart disease.
    Atherosclerosis. 2018;274:104-111.
    PubMed     Text format     Abstract available
    
    
    
20. SHEN ZX, Yang QZ, Li C, Du LJ, et al
    Myeloid peroxisome proliferator-activated receptor gamma deficiency aggravates myocardial infarction in mice.
    Atherosclerosis. 2018;274:199-205.
    PubMed     Text format     Abstract available
    
    
    
21. RAGGI P
    Angina severity, therapeutic choices and outcome in patients with diabetes mellitus.
    Atherosclerosis. 2018 May 3. pii: S0021-9150(18)30223.
    PubMed     Text format    
    
    
    
22. HUMPHRIES SE, Cooper JA, Seed M, Capps N, et al
    Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register.
    Atherosclerosis. 2018;274:41-46.
    PubMed     Text format     Abstract available
    
    
    April 2018
23. WILCOX T, Newman JD, Maldonado TS, Rockman C, et al
    Peripheral vascular disease risk in diabetic individuals without coronary heart disease.
    Atherosclerosis. 2018 Apr 30. pii: S0021-9150(18)30211.
    PubMed     Text format     Abstract available
    
    
    
24. LAVIN B, Protti A, Lorrio S, Dong X, et al
    MRI with gadofosveset: A potential marker for permeability in myocardial infarction.
    Atherosclerosis. 2018 Apr 25. pii: S0021-9150(18)30209.
    PubMed     Text format     Abstract available
    
    
    March 2018
25. DHAR I, Lysne V, Seifert R, Svingen GFT, et al
    Plasma methionine and risk of acute myocardial infarction: Effect modification by established risk factors.
    Atherosclerosis. 2018;272:175-181.
    PubMed     Text format     Abstract available
    
    
    
26. WILLIAMS BA, Chagin KM, Bash LD, Boden WE, et al
    External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction.
    Atherosclerosis. 2018;272:80-86.
    PubMed     Text format     Abstract available
    
    
    
27. CARLSSON AC, Jansson JH, Soderberg S, Ruge T, et al
    Levels of soluble tumor necrosis factor receptor 1 and 2, gender, and risk of myocardial infarction in Northern Sweden.
    Atherosclerosis. 2018;272:41-46.
    PubMed     Text format     Abstract available
    
    
    February 2018
28. RAGGI P
    Atherosclerosis imaging to refine cardiovascular risk assessment in diabetic patients: Computed tomography and positron emission tomography applications.
    Atherosclerosis. 2018;271:77-83.
    PubMed     Text format     Abstract available
    
    
    
29. YIN H, Pickering JG
    Aortic smooth muscle cells and myocardial infarction: Does the ascending aorta feel a heart attack?
    Atherosclerosis. 2018 Feb 10. pii: S0021-9150(18)30080.
    PubMed     Text format    
    
    
    January 2018
30. PELCZARSKA A, Jakubczyk M, Jakubiak-Lasocka J, Banach M, et al
    The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland.
    Atherosclerosis. 2018;270:132-138.
    PubMed     Text format     Abstract available
    
    
    
31. MARACLE CX, Agca R, Helder B, Meeuwsen JAL, et al
    Noncanonical NF-kappaB signaling in microvessels of atherosclerotic lesions is associated with inflammation, atheromatous plaque morphology and myocardial infarction.
    Atherosclerosis. 2018;270:33-41.
    PubMed     Text format     Abstract available
    
    
    
32. WONGSURAWAT T, Woo CC, Giannakakis A, Lin XY, et al
    Distinctive molecular signature and activated signaling pathways in aortic smooth muscle cells of patients with myocardial infarction.
    Atherosclerosis. 2018 Jan 29. pii: S0021-9150(18)30024.
    PubMed     Text format     Abstract available
    
    
    
33. MULE G, Vadala M, Geraci G, Cottone S, et al
    Retinal vascular imaging in cardiovascular medicine: New tools for an old examination.
    Atherosclerosis. 2018;268:188-190.
    PubMed     Text format    
    
    
    December 2017
34. HAMAZAKI K, Iso H, Eshak ES, Ikehara S, et al
    Plasma levels of n-3 fatty acids and risk of coronary heart disease among Japanese: The Japan Public Health Center-based (JPHC) study.
    Atherosclerosis. 2017 Dec 8. pii: S0021-9150(17)31423.
    PubMed     Text format     Abstract available
    
    
    
35. NISHIHIRA K, Shibata Y, Yamashita A, Kuriyama N, et al
    Relationship between thrombus age in aspirated coronary material and mid-term major adverse cardiac and cerebrovascular events in patients with acute myocardial infarction.
    Atherosclerosis. 2017;268:138-144.
    PubMed     Text format     Abstract available
    
    
    October 2017
36. ERCAN E
    Statin treatment in dialysis patients after acute myocardial infarction improves overall mortality.
    Atherosclerosis. 2017 Oct 23. pii: S0021-9150(17)31348.
    PubMed     Text format     Abstract available
    
    
    September 2017
37. CHUNG CM, Lin MS, Chang CH, Cheng HW, et al
    Moderate to high intensity statin in dialysis patients after acute myocardial infarction: A national cohort study in Asia.
    Atherosclerosis. 2017 Sep 27. pii: S0021-9150(17)31288.
    PubMed     Text format     Abstract available
    
    
    
38. POKHAREL Y, Sharma PP, Qintar M, Lu Y, et al
    High-sensitivity C-reactive protein levels and health status outcomes after myocardial infarction.
    Atherosclerosis. 2017;266:16-23.
    PubMed     Text format     Abstract available
    
    
    
39. SAITO I, Yamagishi K, Kokubo Y, Yatsuya H, et al
    Association of high-density lipoprotein cholesterol concentration with different types of stroke and coronary heart disease: The Japan Public Health Center-based prospective (JPHC) study.
    Atherosclerosis. 2017;265:147-154.
    PubMed     Text format     Abstract available
    
    
    August 2017
40. GITT AK, Lautsch D, Ferrieres J, De Ferrari GM, et al
    Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
    Atherosclerosis. 2017;266:158-166.
    PubMed     Text format     Abstract available
    
    
    
41. ATTARD R, Dingli P, Doggen CJM, Cassar K, et al
    The independent effect of helicobacter pylori infection and elevated gastrin levels on the risk of myocardial infarction.
    Atherosclerosis. 2017;263:e96-e97.
    PubMed     Text format    
    
    
    
42. WOO CC, Wongsurawat T, Soong R, Lee CN, et al
    Distinctive pattern of LET-7B and MIR-30B in human aortic smooth muscle cells of myocardial infarction patients.
    Atherosclerosis. 2017;263:e63.
    PubMed     Text format    
    
    
    
43. KIM TH, Kang K, Kim EM, Park HE, et al
    Mesenchymal stem cells promote the infiltration of myeloid derived suppressor cells in a mouse myocardial infarction model.
    Atherosclerosis. 2017;263:e60.
    PubMed     Text format    
    
    
    
44. KURDI A, De Meyer GRY, Martinet W
    Everolimus attenuates atherosclerotic plaque progression, intraplaque neovascularization, myocardial infarction and sudden death in a mouse model of advanced atherosclerosis.
    Atherosclerosis. 2017;263:e59.
    PubMed     Text format    
    
    
    
45. DOULAMIS I, Tzani A, Konstantopoulos P, Gkogkos A, et al
    Sirtuin-1 and MMP-2 levels in patients with advanced coronary artery disease: A combined index for incidence of myocardial infarction.
    Atherosclerosis. 2017;263:e53.
    PubMed     Text format    
    
    
    
46. RYAZANKINA N, Manchurov V, Vasilieva E, Shpektor A, et al
    Improved in-hospital clinical outcomes in patients with acute ST-elevation myocardial infarction undergoing remote ischemic preconditioning before primary percutaneous coronary intervention.
    Atherosclerosis. 2017;263:e49-e50.
    PubMed     Text format    
    
    
    
47. MARINKOVIC G, Winkler L, Kefene L, Nilsson J, et al
    The alarmin complex S100A8/9 as a potential therapeutic target after myocardial infarction.
    Atherosclerosis. 2017;263:e48-e49.
    PubMed     Text format    
    
    
    
48. PFETSCH V, Sanin V, Jaensch A, Dallmeier D, et al
    Increased concentrations of soluble ST2 independently predict cardiac and total mortality but not non-fatal cardiovascular events in stable coronary heart disease patients.
    Atherosclerosis. 2017;263:e46-e47.
    PubMed     Text format    
    
    
    
49. ANTIOCHOS P, Marques-Vidal P, Virzi J, Pagano S, et al
    Impact of CD14 polymorphisms on anti-apolipoprotein A-1 IGG-related coronary heart disease prediction in the general population.
    Atherosclerosis. 2017;263:e45.
    PubMed     Text format    
    
    
    
50. PECHERINA T, Kashtalap V, Barbarash O
    Effects of statins on inflammatory markers and matrix metalloproteinases in patients with ST-segment elevation myocardial infarction.
    Atherosclerosis. 2017;263:e45-e46.
    PubMed     Text format    
    
    
    
51. BOUZID K, Ben Ahmed H, Boussaid H, Kamoun M, et al
    Relationship between galectin-3 levels in ST elevation myocardial infarction and the burden of atherosclerosis.
    Atherosclerosis. 2017;263:e275.
    PubMed     Text format    
    
    
    
52. NIZOMOV A, Kenjaev S
    Effect of high-dose atorvastatin on lipid spectrum and inflammation in acute myocardial infarction.
    Atherosclerosis. 2017;263:e245-e246.
    PubMed     Text format    
    
    
    
53. AZIZ N, Sirojiddin K, Majid K
    Influence of high doses of atorvastatin on myocardial stanning in acute myocardial infarction.
    Atherosclerosis. 2017;263:e245.
    PubMed     Text format    
    
    
    
54. GRAESDAL A, Dybvig A
    Lipoprotein apheresis as a treatment modality for familial combined hyperlipidemia (FCH) with non-alcoholic fatty liver disease (NAFLD) and coronary heart disease: a casuistic approach.
    Atherosclerosis. 2017;263:e243-e244.
    PubMed     Text format    
    
    
    
55. BATURINA O, Mironova O
    Clinical case of hyperlipidemia type IV in a man with diabetes, myocardial infarction and stroke.
    Atherosclerosis. 2017;263:e227-e228.
    PubMed     Text format    
    
    
    
56. REVNIC CR, Revnic F, Pena C, Nica AS, et al
    Biochemical studies of atherogenic potential of serum from patients with unstable angina coronary atherosclerosis.
    Atherosclerosis. 2017;263:e219-e220.
    PubMed     Text format    
    
    
    
57. QAYYUM F, Lauridsen B, Frikke-Schmidt R, Nordestgaard B, et al
    Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease.
    Atherosclerosis. 2017;263:e21.
    PubMed     Text format    
    
    
    
58. PAPADOPOULOS D, Grassos H, Sanidas E, Barbetseas J, et al
    Triglyceride blood levels and metalloproteinases activity in acute myocardial infarction patients.
    Atherosclerosis. 2017;263:e203.
    PubMed     Text format    
    
    
    
59. FEDOROVA N, Kashtalap V, Barbarash O
    Galectin-3 levels in patients with ST segment elevation myocardial infarction.
    Atherosclerosis. 2017;263:e199.
    PubMed     Text format    
    
    
    
60. PECHERINA T, Kashtalap V, Barbarash O, Zhuravleva E, et al
    The value of matrix metalloproteinases in coronary atherosclerosis progression in patients after ST-segment elevation myocardial infarction in one year.
    Atherosclerosis. 2017;263:e198.
    PubMed     Text format    
    
    
    
61. ZIVOTIC I, Zivkovic M, Djuric T, Stankovic A, et al
    Rs10757278 from 9p21 is associated with ST-elevated myocardial infarction in females in population of Serbia.
    Atherosclerosis. 2017;263:e188.
    PubMed     Text format    
    
    
    
62. FARES AL, Hussein El Bacha AA, Souza CS, Garcia De Carvalho JA, et al
    High prevalence of familial hypercholesterolemia in patients with coronary heart disease at a Brazilian quaternary healthcare center.
    Atherosclerosis. 2017;263:e181-e183.
    PubMed     Text format    
    
    
    
63. DJORDJEVIC A, Zivkovic M, Dekleva M, Markovic-Nikolic N, et al
    SNPS in the vicinity of LGALS-3 locus and different shape-types of heart remodeling after the first myocardial infarction: Preliminary results.
    Atherosclerosis. 2017;263:e180.
    PubMed     Text format    
    
    
    
64. NUSSBAUMEROVA B, Rosolova H, Mayer O Jr, Filipovsky J, et al
    Residual cardiovascular risk in patients with stable coronary heart disease over the last 16 years (Czech part of the EUROASPIRE I-IV surveys).
    Atherosclerosis. 2017;263:e177.
    PubMed     Text format    
    
    
    
65. KASHTALAP V, Barbarash O, Gorbunova E, Sedyh D, et al
    Psychophysiological personality characteristics of patients with recurrent myocardial infarction.
    Atherosclerosis. 2017;263:e174.
    PubMed     Text format    
    
    
    
66. IGNATEVA O, Berkovich O, Volkova E, Moroshkina N, et al
    S19W polymorphism of apo AV is an independent risk factor for myocardial infarction among young men.
    Atherosclerosis. 2017;263:e173-e174.
    PubMed     Text format    
    
    
    
67. DIAZ-PEROMINGO JA, Macia-Rodriguez C, Alende-Castro V, Paez-Guillan E, et al
    Comorbidity and sex differences among patients with ischemic heart disease currently smokers.
    Atherosclerosis. 2017;263:e172.
    PubMed     Text format    
    
    
    
68. KECHIDA M, Jomaa W, Hamda KB, Klii R, et al
    Myocardial infarction as a first symptom of activated protein C resistance associated to hyperhomocyteinemia.
    Atherosclerosis. 2017;263:e162.
    PubMed     Text format    
    
    
    
69. NIZOMOV A, Kenjaev M, Kenjaev S, Kenjaev S, et al
    The relationship between the parameters of longitudinal systolic function and left ventricular remodeling in patients with acute myocardial infarction.
    Atherosclerosis. 2017;263:e159.
    PubMed     Text format    
    
    
    
70. HONG TJ, Lee HW, Choi JH, Choi JC, et al
    Comparison of long term clinical outcomes between bare metal stent versus different types of drug eluting stents for treatment of acute myocardial infarction.
    Atherosclerosis. 2017;263:e155-e156.
    PubMed     Text format    
    
    
    
71. SHALAEVA A, Dadabaeva N
    Compliance initiatives in management of patients with coronary artery disease after acute myocardial infarction.
    Atherosclerosis. 2017;263:e152-e153.
    PubMed     Text format    
    
    
    
72. SHAH N, Meira L, Elliott R, Bordin D, et al
    DNA repair measuring DNA ligase activity in non ST-elevation myocardial infarction determines atherosclerotic plaque instability.
    Atherosclerosis. 2017;263:e143.
    PubMed     Text format    
    
    
    
73. SHAH N, Meira L, Forrer-Charlier C, Mahmoudi M, et al
    Up-regulation of base excision repair gene 8-oxoguanine glycosylase 1 expression in non ST-elevation myocardial infarction and correlation with atherosclerotic fibrous cap thickness.
    Atherosclerosis. 2017;263:e142-e143.
    PubMed     Text format    
    
    
    
74. ROMANOVA V
    Condition of adhesive endothelial function in coronary heart disease patients.
    Atherosclerosis. 2017;263:e141.
    PubMed     Text format    
    
    
    
75. DUMITRIU IE, Bulenkamp J, Chhetri I
    Homeostatic cytokines interleukin-7 (IL-7) and IL-15 drive the expansion and activation of CD4+CD28null t cells in patients with myocardial infarction.
    Atherosclerosis. 2017;263:e14-e15.
    PubMed     Text format    
    
    
    
76. NIZOMOV A, Kenjaev S, Kenjaev M, Mukhamedova M, et al
    Dynamics of indicators of longitudinal left ventricular systolic function in patients with acute myocardial infarction during stress echocardiography with dobutamine.
    Atherosclerosis. 2017;263:e122.
    PubMed     Text format    
    
    
    
77. MUSIKHINA N, Petelina T, Gapon L, Emeneva I, et al
    Peculiarity of vascular inflammatory response in patients with unstable angina.
    Atherosclerosis. 2017;263:e118.
    PubMed     Text format    
    
    
    
78. VERWEIJ S, Delewi R, Stiekema L, Versloot M, et al
    Prolonged inflammatory state after myocardial infarction.
    Atherosclerosis. 2017;263:e117-e118.
    PubMed     Text format    
    
    
    
79. KUMAR V
    Demonstrating the decline in coronary heart disease mortality in the Central Delhi, India between 2010 to 2015.
    Atherosclerosis. 2017;263:e110.
    PubMed     Text format    
    
    
    
80. DE GONZALO CALVO D, Sanchez Vega J, Vilades D, Nasarre L, et al
    Diagnostic value of circulating miRNAs: Association with the presence and extension of coronary atherosclerosis in patients with suspected ischemic heart disease.
    Atherosclerosis. 2017;263:e106.
    PubMed     Text format    
    
    
    July 2017
81. AGARWALA A, Pokharel Y, Saeed A, Sun W, et al
    The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.
    Atherosclerosis. 2017;262:131-137.
    PubMed     Text format     Abstract available
    
    
    
82. HOLMLUND A, Lampa E, Lind L
    Oral health and cardiovascular disease risk in a cohort of periodontitis patients.
    Atherosclerosis. 2017;262:101-106.
    PubMed     Text format     Abstract available
    
    
    
83. CHUNG RWS, Leanderson P, Lundberg AK, Jonasson L, et al
    Lutein exerts anti-inflammatory effects in patients with coronary artery disease.
    Atherosclerosis. 2017;262:87-93.
    PubMed     Text format     Abstract available
    
    
    
84. TOUTOUZAS K, Benetos G, Koutagiar I, Barampoutis N, et al
    Noninvasive detection of increased carotid artery temperature in patients with coronary artery disease predicts major cardiovascular events at one year: Results from a prospective multicenter study.
    Atherosclerosis. 2017;262:25-30.
    PubMed     Text format     Abstract available
    
    
    
85. ZHANG Q, Wang A, Zhang S, Li N, et al
    Asymptomatic polyvascular disease and the risks of cardiovascular events and all-cause death.
    Atherosclerosis. 2017;262:1-7.
    PubMed     Text format     Abstract available
    
    
    
86. CHO I, O Hartaigh B, Gransar H, Valenti V, et al
    Prognostic implications of coronary artery calcium in the absence of coronary artery luminal narrowing.
    Atherosclerosis. 2017;262:185-190.
    PubMed     Text format     Abstract available
    
    
    June 2017
87. VONGPROMEK R, Bos S, Ten Kate GR, Bujo H, et al
    Soluble LR11 associates with aortic root calcification in asymptomatic treated male patients with familial hypercholesterolemia.
    Atherosclerosis. 2017 Jun 9. pii: S0021-9150(17)30268.
    PubMed     Text format     Abstract available
    
    
    
88. FAIROOZY RH, Cooper J, White J, Giambartolomei C, et al
    Identifying low density lipoprotein cholesterol associated variants in the Annexin A2 (ANXA2) gene.
    Atherosclerosis. 2017;261:60-68.
    PubMed     Text format     Abstract available
    
    
    
89. WANG A, Kwee LC, Grass E, Neely ML, et al
    Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome.
    Atherosclerosis. 2017;261:19-25.
    PubMed     Text format     Abstract available
    
    
    
90. NAKAJIMA S, Ito H, Mitsuhashi T, Kubo Y, et al
    Clinical application of effective atomic number for classifying non-calcified coronary plaques by dual-energy computed tomography.
    Atherosclerosis. 2017;261:138-143.
    PubMed     Text format     Abstract available
    
    
    
91. TADA H, Kawashiri MA, Sakata K, Yoneda T, et al
    Renal glucosuria is not associated with atherosclerotic cardiovascular disease outcome in a general Japanese community.
    Atherosclerosis. 2017;261:111-116.
    PubMed     Text format     Abstract available
    
    
    May 2017
92. SHARIFI M, Higginson E, Bos S, Gallivan A, et al
    Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.
    Atherosclerosis. 2017 May 13. pii: S0021-9150(17)30218.
    PubMed     Text format     Abstract available
    
    
    
93. GLEISSNER CA, Erbel C, Linden F, Domschke G, et al
    Galectin-3 binding protein, coronary artery disease and cardiovascular mortality: Insights from the LURIC study.
    Atherosclerosis. 2017;260:121-129.
    PubMed     Text format     Abstract available
    
    
    
94. VERDOIA M, Nardin M, Rolla R, Marino P, et al
    Immature platelet fraction and the extent of coronary artery disease: A single centre study.
    Atherosclerosis. 2017;260:110-115.
    PubMed     Text format     Abstract available
    
    
    
95. PANH L, Ruidavets JB, Rousseau H, Petermann A, et al
    Association between serum alkaline phosphatase and coronary artery calcification in a sample of primary cardiovascular prevention patients.
    Atherosclerosis. 2017;260:81-86.
    PubMed     Text format     Abstract available
    
    
    
96. BASKARAN L, O Hartaigh B, Schulman-Marcus J, Gransar H, et al
    Dense calcium and lesion-specific ischemia: A comparison of CCTA with fractional flow reserve.
    Atherosclerosis. 2017;260:163-168.
    PubMed     Text format     Abstract available
    
    
    April 2017
97. MANGILI LC, Miname MH, Silva PRS, Bittencourt MS, et al
    Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study.
    Atherosclerosis. 2017 Apr 30. pii: S0021-9150(17)30189.
    PubMed     Text format     Abstract available
    
    
    
98. KITAHARA H, Waseda K, Sakamoto K, Yamada R, et al
    Impact of attenuated-signal plaque observed by intravascular ultrasound on vessel response after drug-eluting stent implantation.
    Atherosclerosis. 2017;259:68-74.
    PubMed     Text format     Abstract available
    
    
    March 2017
99. LI S, Wu NQ, Zhu CG, Zhang Y, et al
    Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.
    Atherosclerosis. 2017;260:67-74.
    PubMed     Text format     Abstract available
    
    
    
100. KITAGAWA K, Amano T, Uetani T, Ishii H, et al
     Association between plaque characteristics and the amount of debris captured by a filter-type distal protection device in patients with acute coronary syndrome.
     Atherosclerosis. 2017;258:72-78.
     PubMed     Text format     Abstract available
     
     
     
101. KWON CH, Kang JG, Lee HJ, Kim NH, et al
     Absence of association between gallstone and coronary artery calcification.
     Atherosclerosis. 2017;258:51-55.
     PubMed     Text format     Abstract available
     
     
     
102. RIZVI A, Hartaigh BO, Danad I, Han D, et al
     Diffuse coronary artery disease among other atherosclerotic plaque characteristics by coronary computed tomography angiography for predicting coronary vessel-specific ischemia by fractional flow reserve.
     Atherosclerosis. 2017;258:145-151.
     PubMed     Text format     Abstract available
     
     
     
103. ABD-ELMONIEM KZ, Ramos N, Yazdani SK, Ghanem AM, et al
     Coronary atherosclerosis and dilation in hyper IgE syndrome patients: Depiction by magnetic resonance vessel wall imaging and pathological correlation.
     Atherosclerosis. 2017;258:20-25.
     PubMed     Text format     Abstract available
     
     
     
104. SHAHID SU, Shabana, Cooper JA, Beaney KE, et al
     Genetic risk analysis of coronary artery disease in Pakistani subjects using a genetic risk score of 21 variants.
     Atherosclerosis. 2017;258:1-7.
     PubMed     Text format     Abstract available
     
     
     
105. CAMPOS AM, Moura FA, Santos SN, Freitas WM, et al
     Sarcopenia, but not excess weight or increased caloric intake, is associated with coronary subclinical atherosclerosis in the very elderly.
     Atherosclerosis. 2017;258:138-144.
     PubMed     Text format     Abstract available
     
     
     
106. MADSEN DM, Diederichsen ACP, Hosbond SE, Gerke O, et al
     Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease.
     Atherosclerosis. 2017;258:131-137.
     PubMed     Text format     Abstract available
     
     
     February 2017
107. CHRISTIANSEN MK, Nyegaard M, Pedersen LN, Larsen SB, et al
     A 45-SNP genetic risk score is increased in early-onset coronary artery disease but independent of familial disease clustering.
     Atherosclerosis. 2017;257:172-178.
     PubMed     Text format     Abstract available
     
     
     
108. OSAWA K, Nakanishi R, Budoff MJ
     Is there a role for coronary artery calcification scoring in primary prevention of cerebrovascular disease?
     Atherosclerosis. 2017;257:279-287.
     PubMed     Text format     Abstract available
     
     
     
109. LIN JF, Wu S, Juang JJ, Chiang FT, et al
     IL1RL1 single nucleotide polymorphism predicts sST2 level and mortality in coronary and peripheral artery disease.
     Atherosclerosis. 2017;257:71-77.
     PubMed     Text format     Abstract available
     
     
     
110. DE VRIES MA, Trompet S, Mooijaart SP, Smit RA, et al
     Complement receptor 1 gene polymorphisms are associated with cardiovascular risk.
     Atherosclerosis. 2017;257:16-21.
     PubMed     Text format     Abstract available
     
     
     
111. KIM J, Budoff MJ, Nasir K, Wong ND, et al
     Thoracic aortic calcium, cardiovascular disease events, and all-cause mortality in asymptomatic individuals with zero coronary calcium: The Multi-Ethnic Study of Atherosclerosis (MESA).
     Atherosclerosis. 2017;257:1-8.
     PubMed     Text format     Abstract available
     
     
     
112. LEE EM, Choi MH, Seo HS, Kim HK, et al
     Impact of vasomotion type on prognosis of coronary artery spasm induced by acetylcholine provocation test of left coronary artery.
     Atherosclerosis. 2017;257:195-200.
     PubMed     Text format     Abstract available
     
     
     
113. CHEEZUM MK, Kim A, Bittencourt MS, Kassop D, et al
     Association of tobacco use and cessation with coronary atherosclerosis.
     Atherosclerosis. 2017;257:201-207.
     PubMed     Text format     Abstract available
     
     
     January 2017
114. MAILE LA, Busby WH, Xi G, Gollahan KP, et al
     An anti-alphaVbeta3 antibody inhibits coronary artery atherosclerosis in diabetic pigs.
     Atherosclerosis. 2017;258:40-50.
     PubMed     Text format     Abstract available
     
     
     
115. WIDHALM K, Benke IM, Fritz M, Geiger H, et al
     Homozygous familial hypercholesterolemia: Summarized case reports.
     Atherosclerosis. 2017;257:86-89.
     PubMed     Text format     Abstract available
     
     
     
116. BRUCKERT E, Kalmykova O, Bittar R, Carreau V, et al
     Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.
     Atherosclerosis. 2017;257:130-137.
     PubMed     Text format     Abstract available
     
     
     
117. BOS S, Duvekot MH, Ten Kate GR, Verhoeven AJ, et al
     Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study.
     Atherosclerosis. 2017;256:62-66.
     PubMed     Text format     Abstract available
     
     
     
118. NONIN S, Iwata S, Sugioka K, Fujita S, et al
     Plaque surface irregularity and calcification length within carotid plaque predict secondary events in patients with coronary artery disease.
     Atherosclerosis. 2017;256:29-34.
     PubMed     Text format     Abstract available
     
     
     December 2016
119. LEE DH, Chun EJ, Hur JH, Min SH, et al
     Effect of sarpogrelate, a selective 5-HT2A receptor antagonist, on characteristics of coronary artery disease in patients with type 2 diabetes.
     Atherosclerosis. 2016;257:47-54.
     PubMed     Text format     Abstract available
     
     
     November 2016
120. SCICALI R, Giral P, Gallo A, Di Pino A, et al
     HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients.
     Atherosclerosis. 2016;255:102-108.
     PubMed     Text format     Abstract available
     
     
     
121. NAKANISHI R, Ceponiene I, Osawa K, Luo Y, et al
     Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study.
     Atherosclerosis. 2016;255:73-79.
     PubMed     Text format     Abstract available
     
     
     October 2016
122. OGURA M, Makino H, Kamiya C, Yoshimatsu J, et al
     Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion.
     Atherosclerosis. 2016;254:179-183.
     PubMed     Text format     Abstract available
     
     
     September 2016
123. MANGILI LC, Mangili OC, Bittencourt MS, Miname MH, et al
     Epicardial fat is associated with severity of subclinical coronary atherosclerosis in familial hypercholesterolemia.
     Atherosclerosis. 2016;254:73-77.
     PubMed     Text format     Abstract available
     
     
     August 2016
124. ALONSO R, Mata P, Muniz O, Fuentes-Jimenez F, et al
     PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia.
     Atherosclerosis. 2016 Aug 27. pii: S0021-9150(16)31306.
     PubMed     Text format     Abstract available
     
     
     
125. IKEDA N, Hara H, Hiroi Y, Nakamura M, et al
     Impact of serum 1,5-anhydro-d-glucitol level on prediction of major adverse cardiac and cerebrovascular events in non-diabetic patients without coronary artery disease.
     Atherosclerosis. 2016;253:1-6.
     PubMed     Text format     Abstract available
     
     
     July 2016
126. WATTS GF, Pang J, Chan DC, Brunt JN, et al
     Angiographic progression of coronary atherosclerosis in patients with familial hypercholesterolaemia treated with non-statin therapy: Impact of a fat-modified diet and a resin.
     Atherosclerosis. 2016;252:82-87.
     PubMed     Text format     Abstract available
     
     
     May 2016
127. NARDIN M, Verdoia M, Schaffer A, Barbieri L, et al
     Vitamin D status, diabetes mellitus and coronary artery disease in patients undergoing coronary angiography.
     Atherosclerosis. 2016;250:114-121.
     PubMed     Text format     Abstract available
     
     
     
128. MENEGAUT L, Masson D, Abello N, Denimal D, et al
     Specific enrichment of 2-arachidonoyl-lysophosphatidylcholine in carotid atheroma plaque from type 2 diabetic patients.
     Atherosclerosis. 2016 May 4. pii: S0021-9150(16)30164.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: